Skip to main content

Table 3 Difference of other indexes between the NE and FE-CB phenotypes

From: The characteristics of the frequent exacerbator with chronic bronchitis phenotype and non-exacerbator phenotype in patients with chronic obstructive pulmonary disease: a meta-analysis and system review

Secondary outcomes

included studies

MD

95% CI

P

I2, P

the quantity of cigarettes smoked (pack-years)

Six studies

3.09

(1.60,4.58)

< 0.001

41%, 0.14

CAT score

Eight studies

5.61

(4.62,6.60)

< 0.001

80%, < 0.001

mMRC score

Four studies

0.72

(0.63,0.82)

< 0.001

57%, 0.07

BMI

Seven studies

-0.14

(−0.70,0.42)

0.62

75%, < 0.001

Charlson comorbidity index

Three studies

0.47

(0.37,0.58)

< 0.001

0, 0.70

BODEx

Three studies

1.78

(1.28,2.28)

< 0.001

91%, < 0.001

  1. CI: confidence interval; CAT: COPD assessment test; BMI: body mass index; mMRC: modified British Medical Research Council dyspnea scale; BODEx: BMI, obstruction, dyspnea, exacerbations